#Shionogi has reached a $2 billion agreement to buy Anglo-US biotech #IntraBio and its recently approved #Aqneursa therapy for two rare #geneticdisorders.
@pharmaphorum.bsky.socialExplore
@pharmaphorum.bsky.social
@pharmaphorum.bsky.social#Shionogi has reached a $2 billion agreement to buy Anglo-US biotech #IntraBio and its recently approved #Aqneursa therapy for two rare #geneticdisorders.